Periodontal Disease, Inflammatory Cytokines, and PGE 2 in Pregnant Patients at Risk of Preterm Delivery: A Pilot Study
Infectious Diseases in Obstetrics and Gynecology · 01.08.2018 · 2018 · 1-7
DOI: 10.1155/2018/7027683 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infectious Diseases in Obstetrics and Gynecology, erschienen am 01.08.2018. Verfasst von Catalina Latorre Uriza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigaciones Odontológicas (CIO), Professor Graduate Program in Periodontics, Faculty of Dentistry, Pontificia Universidad Javeriana, Co…. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pontificia Universidad Javeriana.
Abstract (Originalsprache)
Periodontal disease is an infection that, in pregnant women, can act as a risk factor for preterm delivery by increasing local and systemic inflammatory responses.
Objective
To analyze the presence of periodontal disease, proinflammatory cytokines, and prostaglandin E 2 (PGE 2 ) in pregnant patients at high risk for preterm delivery. Materials and Methods . Pilot study for a case-control study. We included 46 pregnant patients (23 patients at risk of preterm delivery as cases and 23 patients without risk of preterm delivery as controls). We excluded patients who received periodontal treatment, antibiotics, or antimicrobials over the last 3 months as well as those with infections or diseases such as diabetes or hypercholesterolemia. The patients underwent a periodontal assessment, and their levels of cytokines (interleukin- [IL-] 2, IL-6, IL-10, and tumor necrosis factor- [TNF-] α ) and prostaglandin E 2 (PGE 2 ) were quantified.
Results
Patients with periodontal disease showed higher levels of cytokines (IL-2, IL-6, IL-10, and TNF- α ) and PGE 2 . Patients at high risk for preterm birth showed higher IL levels compared with patients at low risk for preterm delivery. PGE 2 increased with the severity of periodontal disease. PGE 2 was higher in patients at low risk for preterm delivery, although this difference was not significant.
Conclusion
Periodontal disease can increase the systemic inflammatory response as well as the levels of PGE 2 and inflammatory cytokines in pregnant patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centro de Investigaciones Odontológicas (CIO), Professor Graduate Program in Periodontics, Faculty of Dentistry, Pontificia Universidad Javeriana, Colombia.
- Centro de Investigaciones Odontológicas (CIO), Faculty of Dentistry, Pontificia Universidad Javeriana, Bogotá, Colombia.
- Hospital Universitario San Ignacio, Colombia.
- Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Pontificia Universidad Javeriana, Colombia.
ORCID-Profile: Francina Maria Escobar Arregoces
Förderung
- Pontificia Universidad Javeriana
Zitieren
APA
Latorre Uriza, C., Velosa-Porras, J., Roa, N. S., Quiñones Lara, S. M., Silva, J., Ruiz, A. J., & Escobar Arregoces, F. M. (2018). Periodontal Disease, Inflammatory Cytokines, and PGE 2 in Pregnant Patients at Risk of Preterm Delivery: A Pilot Study. Infectious Diseases in Obstetrics and Gynecology, 2018, 1-7. https://doi.org/10.1155/2018/7027683
Vancouver
Latorre Uriza C, Velosa-Porras J, Roa NS, Quiñones Lara SM, Silva J, Ruiz AJ, et al. Periodontal Disease, Inflammatory Cytokines, and PGE 2 in Pregnant Patients at Risk of Preterm Delivery: A Pilot Study. Infectious Diseases in Obstetrics and Gynecology. 2018;2018:1-7. doi:10.1155/2018/7027683
BibTeX
@article{LatorreUriza2018,
author = {Latorre Uriza, Catalina and Velosa-Porras, Juliana and Roa, Nelly S and Quiñones Lara, Stephani Margarita and Silva, Jaime and Ruiz, Alvaro J and Escobar Arregoces, Francina Maria},
title = {Periodontal Disease, Inflammatory Cytokines, and PGE 2 in Pregnant Patients at Risk of Preterm Delivery: A Pilot Study},
journal = {Infectious Diseases in Obstetrics and Gynecology},
year = {2018},
volume = {2018},
pages = {1--7},
doi = {10.1155/2018/7027683}
}
EUVIMED